Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Glatstein

Showing results (331-340 of 351) with videos related to

Pageof 36
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremityJ C Yang, A E Chang, A R Baker, et al.
Journal of Biomedical Optics|July 7, 2007
Quantitative comparison of tissue oxygen and motexafin lutetium uptake by ex vivo and noninvasive in vivo techniques in patients with intraperitoneal carcinomatosisHsing-Wen Wang, Jarod C Finlay, Kijoon Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2020
Research-Driven Radiation Oncology: A Narrative on the Ongoing Legacy of Henry S. KaplanEli J Glatstein Md, C Norman Coleman Md, David A Pistenmaa Md PhD, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's diseaseD L Longo, E Glatstein, P L Duffey, et al.
The Pediatric Infectious Disease Journal|August 11, 2011
An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 valuesEduardo L López, Maria M Contrini, Eduardo Glatstein, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|March 29, 2006
Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancerKosmas Verigos, Diana C Hsiung Stripp, Rosemarie Mick, et al.
Practical Radiation Oncology|March 10, 2017
State of dose prescription and compliance to international standard (ICRU-83) in intensity modulated radiation therapy among academic institutionsIndra J Das, Aaron Andersen, Zhe Jay Chen, et al.
Urology|August 1, 1997
Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladderM M Walther, T F Delaney, P D Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patientsTheresa M Busch, Stephen M Hahn, E Paul Wileyto, et al.
Antimicrobial Agents and Chemotherapy|October 14, 2009
Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coliEduardo L López, Maria M Contrini, Eduardo Glatstein, et al.
Pageof 36

Showing results (331-340 of 351) with videos related to

Sort By:
Pageof 36
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremityJ C Yang, A E Chang, A R Baker, et al.
Journal of Biomedical Optics|July 7, 2007
Quantitative comparison of tissue oxygen and motexafin lutetium uptake by ex vivo and noninvasive in vivo techniques in patients with intraperitoneal carcinomatosisHsing-Wen Wang, Jarod C Finlay, Kijoon Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2020
Research-Driven Radiation Oncology: A Narrative on the Ongoing Legacy of Henry S. KaplanEli J Glatstein Md, C Norman Coleman Md, David A Pistenmaa Md PhD, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's diseaseD L Longo, E Glatstein, P L Duffey, et al.
The Pediatric Infectious Disease Journal|August 11, 2011
An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 valuesEduardo L López, Maria M Contrini, Eduardo Glatstein, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|March 29, 2006
Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancerKosmas Verigos, Diana C Hsiung Stripp, Rosemarie Mick, et al.
Practical Radiation Oncology|March 10, 2017
State of dose prescription and compliance to international standard (ICRU-83) in intensity modulated radiation therapy among academic institutionsIndra J Das, Aaron Andersen, Zhe Jay Chen, et al.
Urology|August 1, 1997
Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladderM M Walther, T F Delaney, P D Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patientsTheresa M Busch, Stephen M Hahn, E Paul Wileyto, et al.
Antimicrobial Agents and Chemotherapy|October 14, 2009
Safety and pharmacokinetics of urtoxazumab, a humanized monoclonal antibody, against Shiga-like toxin 2 in healthy adults and in pediatric patients infected with Shiga-like toxin-producing Escherichia coliEduardo L López, Maria M Contrini, Eduardo Glatstein, et al.
Pageof 36